Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone

Keun-Sik Hong1, Seung-Hoon Lee1, Eung Gyu Kim1

  • 1From the Department of Neurology, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea (K.-S.H., Y.-J.C.); Department of Neurology (S.-H.L., B.-W.Y.) and Department of Diagnostic Radiology (C.-H.S.), Seoul National University Hospital, Republic of Korea; Department of Neurology, Inje University Busan Paik Hospital, Republic of Korea (E.G.K.); Department of Neurology, Chonnam National University Hospital, Gwangju, Republic of Korea (K.-H.C.); Department of Neurology, Kyung Hee University Medical Center, Seoul, Republic of Korea (D.I.C.); Department of Neurology, Inha University Hospital, Incheon, Republic of Korea (J.-H.R.); Department of Neurology, Seoul National University Bundang Hospital, Gyeonggi-do, Republic of Korea (H.-J.B.); Department of Neurology, Soonchunhyang University Hospital, Seoul, Republic of Korea (K.B.L.); Department of Neurology, Dongguk University Medical Center, Goyang, Republic of Korea (D.E.K.); Department of Neurology, Eulji General Hospital, Seoul, Republic of Korea (J.-M.P.); Department of Neurology, Konkuk University Medical Center, Seoul, Republic of Korea (H.-Y.K.); Department of Neurology, Dong-A University Hospital, Busan, Republic of Korea (J.-K.C.); Department of Neurology, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea (K.-H.Y.); Department of Neurology, SMG-SNU Boramae Medical Center, Seoul, Republic of Korea (Y.-S.L.); Department of Neurology, Eulji University Hospital, Daejeon, Republic of Korea (S.J.L.); Department of Neurology, Jeju National University Hospital, Republic of Korea (J.C.C.); Department of Neurology, Asan Medical Center, Seoul, Republic of Korea (S.U.K., D.-W.K.); Department of Neurology, Samsung Medical Center, Seoul, Republic of Korea (G.-M.K.); Department of Neurology, Dongsan Medical Center, Keimyung University, Daegu, Republic of Korea (S.-I.S.); Department of Neurology, Chung-Ang University Hospital, Seoul, Republic of Korea (K.-Y.P.); and Department of Neurology, Yeungnam Uni

Stroke
|July 16, 2016
PubMed
Abstract

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
373
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
503
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
405
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
637